Vitamin D and oestrogen receptor polymorphisms in developmental dysplasia of the hip and primary protrusio acetabuli – A preliminary study by Kapoor, Birender et al.
BioMed  Central
Page 1 of 5
(page number not for citation purposes)
Journal of Negative Results in 
BioMedicine
Open Access Brief report
Vitamin D and oestrogen receptor polymorphisms in 
developmental dysplasia of the hip and primary protrusio acetabuli 
– A preliminary study
Birender Kapoor1, Colin Dunlop2, Charles Wynn-Jones3, Anthony A Fryer4, 
Richard C Strange4 and Nicola Maffulli*3
Address: 1Department of Trauma and Orthopaedic Surgery, Arrowe Park Hospital, Arrowe Park Road, Upton, Wirral. CH49 5PE, UK, 2Department 
of Trauma and Orthopaedic Surgery, Ninewells Hospital, Dundee. DD1 9SY, UK, 3Department of Trauma and Orthopaedic Surgery, Keele 
University School of Medicine, University Hospital of North Staffordshire, Thornburrow Drive, Hartshill, Stoke on Trent, Staffordshire, ST4 7QB, 
UK and 4Human Genomics Research Group, Institute for Science and Technology in Medicine, Keele University School of Medicine, University 
Hospital of North Staffordshire, Thornburrow Drive, Hartshill, Stoke on Trent, Staffordshire, ST4 7QB, UK
Email: Birender Kapoor - beenu71@hotmail.com; Colin Dunlop - beenu71@hotmail.com; Charles Wynn-Jones - osa14@keele.ac.uk; 
Anthony A Fryer - a.a.fryer@pmed.keele.ac.uk; Richard C Strange - r.c.strange@path.keele.ac.uk; Nicola Maffulli* - n.maffulli@keele.ac.uk
* Corresponding author    
Abstract
We investigated the association of developmental dysplasia of the hip (DDH) and primary
protrusion acetabuli (PPA) with Vitamin D receptor polymorphisms Taq I and Fok I and oestrogen
receptor polymorphisms Pvu II and Xba I. 45 patients with DDH and 20 patients with PPA were
included in the study. Healthy controls (n = 101) aged 18–60 years were recruited from the same
geographical area. The control subjects had a normal acetabular morphology based on a recent
pelvic radiograph performed for an unrelated cause. DNA was obtained from all the subjects from
peripheral blood. Genotype frequencies were compared in the three groups. The relationship
between the genotype and morphology of the hip joint, severity of the disease, age at onset of
disease and gender were examined. The oestrogen receptor Xba I wild-type genotype (XX,
compared with Xx and xx combined) was more common in the DDH group (55.8%) than controls
(37.9%), though this just failed to achieve statistical significance (p = 0.053, odds ratio = 2.1, 95%
CI = 0.9–4.6). In the DDH group, homozygosity for the mutant Taq I Vitamin D receptor t allele
was associated with higher acetabular index (Mann-Whitney U-test, p = 0.03). Pvu II pp oestrogen
receptor genotype was associated with low centre edge angle (p = 0.07). This study suggests a
possible correlation between gene polymorphism in the oestrogen and vitamin D receptors and
susceptibility to, and severity of DDH. The Taq I vitamin D receptor polymorphisms may be
associated with abnormal acetabular morphology leading to DDH while the Xba I oestrogen
receptor XX genotype may be associated with increased risk o f  d e v e l o p i n g  D D H .  N o  s u c h
correlations were found in the group with PPA.
Published: 28 June 2007
Journal of Negative Results in BioMedicine 2007, 6:7 doi:10.1186/1477-5751-6-7
Received: 4 February 2007
Accepted: 28 June 2007
This article is available from: http://www.jnrbm.com/content/6/1/7
© 2007 Kapoor et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Journal of Negative Results in BioMedicine 2007, 6:7 http://www.jnrbm.com/content/6/1/7
Page 2 of 5
(page number not for citation purposes)
Background
Developmental Dysplasia of the hip (DDH) and Primary
Protrusio Acetabuli (PPA) encompass the spectrum of
acetabular development from a shallow acetabulum in
DDH to a deep acetabulum in PPA. Both have, as yet, an
indeterminate aetiology, variable clinical presentation,
and result in early onset osteoarthritis of the hip [1]. A
genetic aetiology has been proposed in DDH [2], while
the aetiology of PPA is widely debated. Eppinger believed
that PPA results from a failure of normal ossification of
the tri-radiate cartilage [3]. The possible genetic nature of
transmission of this disorder was noted by D'Arcy et al [4].
Idiopathic PPA may represent a hitherto unidentified met-
abolic defect.
Hypothetically, it may be conceived that small numbers
of genomic polymorphisms may well affect acetabular
morphology and capsular laxity, and provide a spectrum
of morphology across the population with the major dys-
morphism leading to clinical apparent disease.
Genetic variation in hormone-related genes may represent
a possible significant determinant of risk or severity, espe-
cially when considering the proposed effect of joint laxity
on DDH [5,6]. The human ESR1 gene is located on chro-
mosome 6q25. It comprises eight exons separated by
seven intronic regions and spans more than 140 kilo-
bases. The most widely studied polymorphic regions are
the Pvu II and Xba I restriction fragment length polymor-
phisms in intron 1 and the (TA) n variable number of tan-
dem repeats (VNTR) within the promoter region of the
gene. The ESR1 is a ligand-activated transcription factor
composed of several domains important for hormone
binding, DNA binding, and activation of transcription.
Alternative splicing results in several ESR1 mRNA tran-
scripts, which differ primarily in their 5' untranslated
regions.
The VDR gene is located on chromosome 12q12–q14. It
contains 11 exons and spans approximately 75 kb. The
Fok I site polymorphism is present in exon 2 of the VDR
gene whereas Taq 1 resides in exon 9. The VDR gene is
associated with osteoporosis [7], osteoarthritis [8,9], and
prostate cancer [10]. The ESR1 gene has been linked with
osteoarthritis [11], osteoporosis [12-16], breast cancer
[17], and testicular cancer [18]. Both genes are involved in
bone metabolism and development.
The VDR and the ESR1 genes are interesting because they
encode proteins that are important transcription factors as
key players in the respective signal transduction pathways.
Several interactions between the vitamin D and oestrogen
endocrine system have been described. 1,25-Dihydroxyvi-
tamin D3 (1,25-(OH)2D3) and 17β-estradiol (E2) have a
mutual effect on their biosynthesis [19,20] and receptor
expression [21]. Also, some genetic studies found an inter-
action between ESR1 and VDR genotypes with respect to
bone density [22]. Suarez et al. found an interactive effect
of ESR1 and VDR gene polymorphisms on growth in
infants [23]. Although oestrogen receptor polymorphisms
have been studied in relation to DDH [24], there has not
yet been a definite evidence of their role in causation.
Also, to our knowledge this approach has not been used
in the study of PPA. We therefore performed a study to
identify the possible association between genetic poly-
morphism at these loci and the presence of DDH and
PPA. We also explored the effect of genotype on acetabu-
lar morphology and severity of the conditions.
Patients and methods
We recruited 45 patient with DDH and 20 patients with
PPA. In all patients, a diagnosis of DDH or PPA was made
on the basis of clinical and radiographic examination. A
control group of 101 subjects (age 18–60) was recruited
from the same geographical region and the same ethnic
group from the hospital radiology database. These sub-
jects had normal hip joints on the basis of recently per-
formed pelvic radiographs for unrelated causes. All
patients and control subjects were Caucasian. The demo-
graphic data on the study population is shown in Table 1.
All participants in this investigation were interviewed and
examined to obtain clinical history, family history, and a
peripheral blood sample through venipuncture. Informed
written consent was obtained from all the subjects prior to
their participation in the study. Ethics approval was
obtained from the Local Research Ethics Committee.
Radiographic measurements
Pelvic radiographs were obtained, and radiographical var-
iables (acetabular index and centre edge angle) of the hip
joint were measured by a single individual using a uni-
form technique (BK). The researcher had been specially
trained in radiographic measurement techniques, and
reached an intra-observer variation of less than two
degrees.
The centre-edge angle was measured as described by Wib-
erg, between a vertical line drawn from the centre of the
Table 1: Demographic details of groups studied
Control DDH PPA
Number 101 45 20
Age – Mean (range) 42.6 (19–60) 46.1 (22–69) 47.5 (28–65)
Age at presentation 
– Mean (range)
NA 14.5 (0–48) 22.05 (5–46)
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femoral head to a line drawn from the centre of the head
to the lateral edge of the acetabulum on antero-posterior
radiographs of the pelvis [25]. The acetabular index was
measured as described by Sharp, between the inter-tear
drop line and the weight bearing dome [26]. The radio-
graphic data of the study population are presented in
Table 2.
Genotype assays
All genotype assays were performed at the Human
Genomics Research Group, University Hospital of North
Staffordshire by two individuals (BK, CD), and the results
validated by an independent, blinded observer examining
the agarose gels (AF). 10% of the assays were repeated and
analysed by an independent observer. The PCR assays
were performed with at least one known DNA genotype
(positive control), one negative control (no DNA), and
known molecular weight markers. At least 15% of the
samples were re-assayed, and the relevant genotype con-
firmed. DNA was extracted from the peripheral blood
samples collected into EDTA using the phenol-chloro-
form extraction method. PCR RFLP-based assays were per-
formed to identify alleles containing Xba I and Pvu II
polymorphisms on the oestrogen receptor 1 (ESR1). Taq I
and Fok I polymorphisms on the vitamin D receptor gene
or VDR were also analysed. The PCR products were then
digested with their respective restriction enzymes and
were examined after electrophoresis on 2% agarose gels.
The wild-type X, P, T, F and mutant x, p, t and f alleles were
identified by the expected fragment sizes following restric-
tion enzyme digestion.
Statistical analysis
Data were analysed using Stata software (version 8, Stata-
Corp, Texas, US). Differences in genotype frequencies of
the ESR1 (Xba I, Pvu II) and VDR (Taq I, Fok I) polymor-
phisms were examined in the three groups using chi-
square tests. Association of genotypes with acetabular
index and centre edge angles was performed using the
Mann-Whitney U test.
Results
Table 3 shows the genotype distribution for the four pol-
ymorphic sites. The oestrogen receptor Xba I wild-type
genotype (XX, compared with Xx and xx combined) was
more common in the DDH group (55.8%) than controls
(37.9%), though this failed to achieve statistical signifi-
cance after Bonferroni correction (p = 0.106). Similarly,
the VDR Fok I ff genotype (compared with FF and Ff com-
bined) was more common in DDH patients than controls
but was not statistically significant (p = 0.18 after Bonfer-
roni correction). No other significant associations were
identified.
The most relevant radiographic variables of both these
conditions (i.e. centre edge angle and acetabular index)
on the affected and non-affected sides were also compared
with genotype. In the DDH group, homozygosity for the
Taq I Vitamin D receptor t  allele was associated with
higher acetabular index on the affected side This was dem-
onstrated using the Mann-Whitney U-test. However, this
again was not statistically significant following Bonferroni
correction. (p = 0.06). In this group, the Pvu II pp oestro-
gen receptor genotype was associated with low centre edge
angle on the affected side though this did not achieve sta-
tistical significance (p = 0.14). No other significant or
near-significant associations were identified.
Discussion
Developmental dysplasia of the hip and primary protru-
sio acetabuli are two common developmental disorders of
Table 3: Genotype frequency
ESR Xba I CONTROL DDH PPA
XX 33(37.9%) 24(55.8%) 6(30%)
Xx 45(51.7%) 18(41.9%) 12(60%)
xx 9(10.3) 1(2.3%) 2(10%)
ESR Pvu II
PP 14(15.2%) 4(8.9%) 5(25%)
Pp 47(51.1%) 27(60%) 11(55%)
pp 31(33.7%) 14(31.1%) 4(20%)
VDR Fok I
FF 33(34.4%) 15(33.3%) 8(42.1%)
Ff 52(54.2%) 20(44.4%) 9(47.4%)
ff 11(11.5%) 10(22.2%) 2(10.5%)
VDR Taq I
TT 31(34.1%) 18(41.9%) 7(43.8%)
Tt 46(50.5%) 20(46.5%) 5(31.3%)
tt 14(15.4%) 5(11.6%) 4(25%)
Table 2: Radiographic variables of the groups studied
Radiographic variable Control Mean (range) DDH Mean (range) PPA Mean (range)
Centre edge angle (left) 34.3 (32.9–35.6) 20.1 (15.4–23.1) 45.1 (35.7–46.0)
Centre edge angle (right) 34 (32.8–35.2) 24 (20.2–28.5) 42.9 (37.9–46.6)
Acetabular index (left) 9.9 (9.2–10.6) 27.4 (24.7–30.5) -4.6 (-7.9–-0.6)
Acetabular index (right) 10.2 (9.4–10.9) 20.3 (16.3–24.2) -3.6 (-7.0–0.5)Journal of Negative Results in BioMedicine 2007, 6:7 http://www.jnrbm.com/content/6/1/7
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the hip joint, with significant associated morbidity. Efforts
have been made for the last 40 years for early identifica-
tion of developmental hip dysplasia, as early correction of
anatomy can produce a hip which has greater chances will
last to late adulthood without major reconstructive sur-
gery [27]. If detected early, secondary osteoarthritis can be
partially prevented or at least delayed. Currently, screen-
ing for DDH in the UK is performed by clinical examina-
tion and ultrasound scanning of patients at risk. Blanket
ultrasound screening has been proposed, but is not signif-
icantly better than at risk or selective screening[28-30].
Therefore, it would be highly desirable to identify predic-
tors to a high risk population.
Aetiological factors for both DDH and PPA are obscure.
There are definite pointers towards a genetic basis, but no
concrete evidence to support it. Some recent studies have
investigated the genetic basis of DDH. Granchi et al found
an association between osteoarthritis secondary to devel-
opmental hip dysplasia and vitamin D receptor polymor-
phism Bsm I. To our knowledge, there are no similar
studies performed for PPA. PPA and DDH may actually
represent two ends of a spectrum in the phenotypic out-
come of a genotypic variation. This formed the basis of
studying same gene polymorphisms for these two condi-
tions.
A detailed study of 589 index patients and 1897 first
degree relatives in the 1960's established a familial trans-
mission in non-syndromic hip dysplasia [31]. There was
significant shallowing of the acetabulum in parents of
children with DDH, and a higher proportion of children
with DDH and their first degree relatives were lax-jointed.
Based on this study, Wynne-Davis proposed two different
gene systems, one affecting joint laxity and the other
affecting the shape of acetabulum to be responsible for
the causation of DDH. Carter and Wilkinson reported
increased incidence of joint laxity with DDH in 1964 [32].
With the recent advances in genetic techniques, there has
been a renewed interest to explore the inheritance of this
disorder. Solazzo et al performed a complex segregational
analysis on 171 pedigrees collected through probands
affected by non-syndromic DDH, and reiterate a two locus
theory [33], against the previous hypothesis that disease
inheritance in familial non-syndromic DDH is polygenic.
The oestrogen receptor Xba I wild-type genotype (XX,
compared with Xx and xx combined) was more common
in the DDH group (55.8%) than controls (37.9%).
Though this failed to achieve significance, it may warrant
further investigation. In the DDH group, homozygosity
for the mutant Taq I Vitamin D receptor t allele was asso-
ciated with higher acetabular index. This may represent an
important aetiological association with DDH. Similarly,
the Pvu II oestrogen receptor was associated with a low
centre edge angle. Though this did not reach significance
it may represent an association with severity of DDH. Our
results are indicative, rather than conclusive, of the associ-
ation between developmental dysplasia of the hip and
oestrogen and vitamin D receptor polymorphisms in the
studied population groups. Our study population was
kept homogenous, and is representative of Caucasian
population in a well defined region of the UK. This was
also disadvantageous in the fact that that the total number
of patients recruited was low. However, the total number
of cases does compare well with other recent genetic stud-
ies on DDH. We are aware of much larger case series of
patients with DDH from tertiary referral centres. However,
these have not been characterised in genetic studies.
Indeed, population homogeneity would be an issue in
larger series due to the current known prevalence of DDH
and PPA in our population.
The present study has shown possible genetic associations
between DDH and vitamin D and oestrogen receptor pol-
ymorphisms. Further work with a larger series of patients
and possibly more candidate gene polymorphisms may
well shed more light on these associations. We hope that
the genetic associations identified in the present study
may lead to more accurate means to identify at risk popu-
lations. The associations, whether positive or negative
may help us to understand the mode of transmission of
this condition.
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